Insights: News Releases Kilpatrick Townsend’s Joseph R. Snyder Appointed to AIPPI’s Standing Committee on Pharma and Biotechnology
WALNUT CREEK (January 24) – Kilpatrick Townsend & Stockton announced today that partner Joe Snyder was recently appointed to AIPPI’s Standing Committee on Pharma and Biotechnology.
The International Association for the Protection of Intellectual Property, known as AIPPI (Association Internationale pour la Protection de la Propriété Intellectuelle), is the world’s leading International Organization dedicated to the development and improvement of laws for the protection of intellectual property.
AIPPI's Standing Committee on Pharma and Biotechnology monitors, comments and advises AIPPI on policy, regulatory and legal frameworks relating to intellectual property protection for pharmaceutical products and processes; diagnostic products; medical devices; and biotechnology (including plant varieties) and biological products. For more information, please click here.
Dr. Snyder is the Managing Partner of the Kilpatrick Townsend’s Walnut Creek office. He focuses his practice on patent prosecution and counseling, emphasizing patent drafting, patent procurement, client counseling and opinion writing, primarily in the chemical arts, biotechnology, life sciences and clean technology. Dr. Snyder represents U.S. and foreign companies, such as pharmaceutical companies, diagnostic laboratories, universities and start-ups in all areas of intellectual property counseling and protection.
Follow the firm on Twitter: @KTS_Law.
While we are pleased to have you contact us by telephone, surface mail, electronic mail, or by facsimile transmission, contacting Kilpatrick Townsend & Stockton LLP or any of its attorneys does not create an attorney-client relationship. The formation of an attorney-client relationship requires consideration of multiple factors, including possible conflicts of interest. An attorney-client relationship is formed only when both you and the Firm have agreed to proceed with a defined engagement.
DO NOT CONVEY TO US ANY INFORMATION YOU REGARD AS CONFIDENTIAL UNTIL A FORMAL CLIENT-ATTORNEY RELATIONSHIP HAS BEEN ESTABLISHED.
If you do convey information, you recognize that we may review and disclose the information, and you agree that even if you regard the information as highly confidential and even if it is transmitted in a good faith effort to retain us, such a review does not preclude us from representing another client directly adverse to you, even in a matter where that information could be used against you.